On May 10, 2021 Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, reported that its management team will discuss data from the abstract of a poster presentation at the American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) 2021 Annual Meeting at a series of investor events in May, beginning with a live corporate webcast on Thursday May 20, 2021 (Press release, Ultimovacs, MAY 10, 2021, View Source [SID1234579614]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The abstract is titled "A Phase I Clinical Trial Investigating the Telomerase Vaccine UV1 in Combination with Pembrolizumab in Patients with Advanced Melanoma". It provides an overview of the open-label, single-arm study investigating the safety and tolerability for the combination of Ultimovacs’ universal cancer vaccine, UV1, with the checkpoint inhibitor pembrolizumab in patients with metastatic malignant melanoma.

The ASCO (Free ASCO Whitepaper) abstract will be made available on the company website on Wednesday, May 19th at 23:00 CEST and will be presented at the ASCO (Free ASCO Whitepaper) 2021 Annual Meeting to be held virtually Friday, June 4, 2021 through Tuesday, June 8, 2021. The full poster presentation from the ASCO (Free ASCO Whitepaper) Annual Meeting will be available on the Ultimovacs website on 4 June 2021.

Details of the investor events:

Event: Live Corporate Webcast
Date/Time: Thursday May 20, 10:00 CEST
Presenter: Carlos de Sousa, CEO. The webcast will be available on the company website, and it will be possible to post questions during the presentation through the webcast.
Webcast Link

Event: Radforsk’s Podcast RADIUM
Date/Time: Thursday May 20, 14:00 CEST
Presenter: Carlos de Sousa, CEO; Jens Bjørheim, CMO. The podcast will be available on the company website.
Podcast Link

Event: 7th Annual Immuno-Oncology Innovation Forum, SACHS associates (18-20th May, 2021)
Date/Time: Thursday May 20, 19:25 CEST
Presenter: Carlos de Sousa, CEO
Meeting link

Event: ABG Sundal Collier Life Science Summit 2021 (held virtually)
Date/Time: Tuesday May 25, 16:00 CEST
Presenter: Carlos de Sousa, CEO

Event: Biostock Life Science Spring Summit (held virtually)
Date/Time: May 26-27
Presenter: Carlos de Sousa, CEO
Meeting link